(Bicalutamide) Casodex vs Placebo in Non-metastatic Early Prostate Cancer
The purpose of this trial is to study the effect of adjuvant or immediate hormonal therapy, versus placebo, in subjects who have either undergone a primary therapy (principally radical prostatectomy or radiotherapy) or who were otherwise to be managed by watchful waiting.
Non-Metastatic Prostate Cancer
DRUG: Bicalutamide|DRUG: Placebo
Time to clinical progression, Throughout study period|Tolerability in terms of adverse events and laboratory parameters, Throughout study period
Survival, Throughout study period|Time to treatment failure, Throughout study period|Prostate-specific antigen, Initial study period up to 2005 amended protocol
The purpose of this trial is to study the effect of adjuvant or immediate hormonal therapy, versus placebo, in subjects who have either undergone a primary therapy (principally radical prostatectomy or radiotherapy) or who were otherwise to be managed by watchful waiting.